Omega Healthcare (OHI) CEO buys 20,000 shares at $43.1428

Omega Healthcare Investors (OHI) reported an insider purchase by its Chief Executive Officer and director.

Accepted by SEC EDGAR 11/06/2025 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Omega Healthcare Investors (OHI) reported an insider purchase by its Chief Executive Officer and director. On 11/05/2025, the reporting person bought 20,000 shares of common stock (transaction code P) at a weighted average price of $43.1428, with individual trade prices ranging from $43.05 to $43.25.

Following the transaction, beneficial ownership consists of 20,000 shares held indirectly through a family trust and 4,100 shares held directly.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 1 txn

Insider PICKETT C TAYLOR

Role CHIEF EXECUTIVE OFFICER

Bought 20,000 shs ($863K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	20,000	$43.1428	$863K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 20,000 shares (Indirect, See Footnote); Common Stock — 4,100 shares (Direct)

Holdings Before and After: Common Stock, 0 to 20,000 shares (Indirect, See Footnote)

Other Insiders: 1 other insider reported open-market purchases of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.05 to $43.25, inclusive. The reporting person undertakes to provide Omega Healthcare Investors, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. F2. Shares owned by a family trust over which the Reporting Person has investment control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OHI disclose in this Form 4?

The CEO and director reported buying 20,000 shares of Omega Healthcare Investors common stock on 11/05/2025.

What was the purchase price for the OHI shares?

The weighted average price was $43.1428, with trades between $43.05 and $43.25.

How many OHI shares does the insider own after the transaction?

Post-transaction holdings include 20,000 shares indirectly via a family trust and 4,100 shares directly.

What was the transaction code on the Form 4?

The transaction code was P, indicating an open-market or private purchase.

What is the insider’s role at Omega Healthcare (OHI)?

The reporting person is the company’s Chief Executive Officer and a director.

Was a trading plan under Rule 10b5-1 indicated?

The filing includes standard language about Rule 10b5-1, but it does not indicate that this purchase was made under such a plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PICKETT C TAYLOR

(Last) (First) (Middle)

303 INTERNATIONAL CIRCLE

SUITE 200

(Street)

HUNT VALLEY MD 21030

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2025		P		20,000	A	$43.1428(1)	20,000	I	See Footnote(2)
Common Stock								4,100	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.05 to $43.25, inclusive. The reporting person undertakes to provide Omega Healthcare Investors, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. Shares owned by a family trust over which the Reporting Person has investment control.

	/s/ Meghan C. Lyons, Attorney-in-Fact	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.